Millrock Technology Taps Biologics Manufacturing Veteran as CEO
Event summary
- Millrock Technology appointed Tom Hochuli as CEO on January 27, 2026.
- Hochuli brings over three decades of experience in life sciences and biologics manufacturing.
- He previously led operational transformations at a biologics-focused organization.
- Millrock specializes in freeze-drying solutions for pharmaceutical and biotech industries.
The big picture
Millrock's appointment of Hochuli underscores the growing importance of advanced manufacturing capabilities in the biopharmaceutical sector. As biologics and complex therapies gain prominence, companies like Millrock are critical enablers for drug developers. Artemis' backing suggests confidence in Millrock's ability to scale its engineering and application expertise.
What we're watching
- Strategic Vision
- How Hochuli's background in biologics manufacturing will shape Millrock's product and market strategy.
- Operational Excellence
- Whether Hochuli can replicate his past successes in operational transformation at Millrock.
- Market Positioning
- The pace at which Millrock can solidify its reputation as a trusted innovator in lyophilization technology.
Related topics